MarketInOut Stock Screener Log In | Sign Up
 

AbbVie Inc

IEX • Healthcare • Drug Manufacturers - General • Quote as of 07/28/2026 15:59
AbbVie Inc stock price and volume chart

Company Profile

IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeIEX
Market Capitalization458,235 mln
Float1,764 mln
Earnings Date07/31/2026

EPS

2.05
Stretched

P / E

129
Highly speculative

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

-2.68
Likely reliable

1-Year Forecast

268
Fairly priced

Relative Strength

91 / 100
Top performer

Business Description

AbbVie is a global pharmaceutical company that develops, manufactures, and sells a wide range of medicines and therapies across many health conditions. Its product portfolio spans immunology, oncology, neuroscience, eye care, and aesthetics, with well-known treatments for blood cancers, autoimmune diseases, migraines, Parkinson's disease, and more. The company also offers cosmetic products such as Botox and the Juvederm collection of facial fillers. Founded in 2012 and based in North Chicago, Illinois, AbbVie operates across markets worldwide.

Key Fundamentals

EPS2.05
P/E129
RPS35.43
ROIC11.24
ROA2.68
Interest Cover7.16
EBITDA, mln16,921
EV / EBITDA30.21
EV / EBIT57.53
Revenue, mln62,819
EV / Revenue8.14

Financial Strength

Altman Z-Score2.29
Piotroski F-Score 5 / 9
Beneish M-Score-2.68
Price to Intrinsic Value2.54
1-Year Target Price268
Shiller PE Ratio55.24
Short Ratio2.42
Short % of Float1.42

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 2.82% 78 / 100   
1 Month 6.12% 80 / 100   
2 Months 30.22% 94 / 100   
6 Months 21.15% 82 / 100   
1 Year 42.66% 77 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us